Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Stents × 90 days × Clear all
NCT06274879 2026-05-26

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT04450758 2026-04-23

ACBC

Skane University Hospital

Recruiting
1,000 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06630910 2026-03-31

whipple

Theodor Bilharz Research Institute

Phase NA Completed
48 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡